Latent Lines

MP — MP

1.52% of the book · +15.73% since entry · entered 2025-11

Reclassification -- T2 High Conviction (2026-05-20)

MP is reclassified from probe-treated T2 to T2 High Conviction with a formal scale-up mandate. Governing policy: MP Policy v0.1 in project/docs/PORTFOLIO_CONTEXT.md (Trading Rules section). Driver: the DoW masses-layer research (project/wiki/entities/department-of-war.md) -- six structural DoW moats (preferred equity, warrant, $150M Samarium loan, $110/kg Price Protection Agreement through 2035, 10X offtake with a $140M EBITDA floor, Maaden JV). MP Policy v0.1 sets a near-term scale-up floor of ~$150-200, a confirmed-thesis ceiling of ~$400-500 gated on the mid-2026 separation-facility commissioning, and Anchor as the trajectory destination (not a current label).

Note on the sections below: the Position / Thesis / Triggers content predates this reclassification (written 2026-05-12) and still uses "1-share probe" framing and a ~$63 cost-basis proxy. Canonical position facts are in data/cost_basis.json; canonical governance is MP Policy v0.1. A full wiki refresh of the sections below is pending.

One-line thesis

Only operating US rare earth mine and the Pentagon's chosen domestic supply chain anchor, backed by $400M DoD equity investment and a 10-year magnet offtake agreement that structurally insulates revenue from spot market volatility.

Position

  • T2 High Conviction position entered May 2026 (STCG profile). Scale-up authorized under MP Policy v0.1; the reclassification banner above carries the framework.
  • Thesis validation gate: mid-2026 separation-facility commissioning at Mountain Pass.

Thesis (detailed)

Mountain Pass in the Mojave Desert is the only operating rare earth mine in the United States, a status that transforms MP Materials from a commodity miner into a national security infrastructure asset. The company produces mixed rare earth carbonate (MREC) and has been systematically building separation and magnet manufacturing capability -- a full vertical integration play in a supply chain that is otherwise 85% dominated by China.

The DoD relationship is not advisory -- it is structural. The Pentagon has committed $400M in convertible preferred equity and warrants, a $150M 12-year loan, a NdPr price floor of $110/kg starting Q4 2025 (guaranteed for 10 years), and a 10-year offtake commitment for 7,000 MT/year of rare earth magnets. This is the US government explicitly designating MP as the domestic REE supply anchor under DPA Title III authorities. No other Western REE company has an arrangement of this scope or this specificity.

The separation facility commissioning (mid-2026 guided) is the next major inflection point. Once operational, MP transitions from concentrate exporter to separated REE producer -- moving up the value chain where China has historically captured most of the margin. The DoD price floor removes the downside scenario of NdPr price collapse that would otherwise be the primary bear case. The remaining risk is execution: the heavy REE separation facility (dysprosium/terbium) is a technically complex expansion that has no domestic precedent at scale.

Recent catalysts (60-day rolling)

  • 2026-Q2 (ongoing): Heavy REE separation facility at Mountain Pass targeting mid-2026 commissioning -- primary catalyst watch; Dy/Tb initially; 3,000 MT/yr feedstock capacity
  • 2025-Q4: DoD NdPr price floor of $110/kg activated -- revenue floor established for 10-year period; structurally important de-risk
  • 2026-ongoing: $92M upsized offering in Western Copper context (separate company; listed here as sector data point only)

Risks / What would break the thesis

  • Separation facility delayed beyond H2 2026 -- value chain upgrade thesis deferred; stock likely gives back recent gains
  • DoD relationship impaired by administration policy shift -- convertible preferred creates alignment but political risk remains on future procurement priorities
  • China rare earth price dumping -- could undercut the NdPr price floor if DoD price support is interpreted narrowly; verify floor mechanism covers spot and contract
  • Heavy REE (Dy/Tb) technical failure at scale -- MP has DoD funding to BUILD the capability, not proven commercial production; lab-to-industrial gap is real (see REE value chain research)

Triggers

  • Separation facility commissioning announcement (mid-2026) -- upgrade from probe to small conviction position if successful
  • Q2 2026 earnings (expect late July/early August): first read on DoD price floor impact on realized NdPr pricing
  • Any DoD contract modification, amendment, or public statement on domestic REE procurement priorities
  • NdPr spot price moves: below $110/kg tests price floor mechanism in practice; above $120/kg suggests thesis outperforming on economics

External authoritative sources

Open questions / hypotheses

  • What is the exact conversion ratio and strike price on the DoD's $400M convertible preferred -- at what share price does that become dilutive to common holders?
  • The DoD price floor is $110/kg for NdPr; what is the current NdPr spot price and how does realized price compare to floor?
  • Is the heavy REE (Dy/Tb) separation facility fully DoD-funded via the $35M DPA Title III grant, or is there additional capex exposure?
  • MP stock is up ~200% in 2025 (per TIKR data) -- at current price near $63, what is analyst consensus target and how much upside remains vs. execution risk?

Decision log

  • 2026-05-12: Wiki page created. 1-share probe. Thesis validation gate: separation facility commissioning mid-2026.
  • 2026-05-20: Reclassified probe-treated T2 -> T2 High Conviction with a formal scale-up mandate (MP Policy v0.1, PORTFOLIO_CONTEXT.md), in the Tranche & Policy Review session. Driven by the DoW masses-layer research. Hybrid accumulation: initial slice authorized now toward a ~$150-200 near-term floor; larger tranche toward a ~$400-500 ceiling gated on the mid-2026 separation-facility commissioning. Anchor is the trajectory destination. See the Reclassification banner at the top of this page.